| Title | Date | PubMed ID |
|---|
| CTSL2 is a pro-apoptotic target of E2F1 and a modulator of histone deacetylase inhibitor and DNA damage-induced apoptosis. | 2014 Mar 6 | 23542171 |
| Tumor necrosis factor alpha stimulates cathepsin K and V activity via juxtacrine monocyte-endothelial cell signaling and JNK activation. | 2012 Aug | 22562303 |
| Expression of cysteine protease cathepsin L is increased in endometrial cancer and correlates with expression of growth regulatory genes. | 2012 Jun | 22452389 |
| Human cathepsin V protease participates in production of enkephalin and NPY neuropeptide neurotransmitters. | 2012 May 4 | 22393040 |
| A simple and efficient protocol for the production of recombinant cathepsin V and other cysteine cathepsins in soluble form in Escherichia coli. | 2012 Mar | 22100277 |
| Manipulating substrate and pH in zymography protocols selectively distinguishes cathepsins K, L, S, and V activity in cells and tissues. | 2011 Dec 1 | 21982919 |
| Structure-activity relationships of hypervalent organochalcogenanes as inhibitors of cysteine cathepsins V and S. | 2011 Mar 15 | 21345684 |
| Acridone alkaloids as potent inhibitors of cathepsin V. | 2011 Feb 15 | 21277783 |
| Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model. | 2010 Nov | 20447439 |
| Expression of human cathepsin L or human cathepsin V in mouse thymus mediates positive selection of T helper cells in cathepsin L knock-out mice. | 2010 Nov | 20347002 |